Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
716 (USA) · Dr. Ito
consented 2013-04-27
AEs
3
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild CONFUSIONAL STATE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-15 (study day 172.0); relationship: POSSIBLE
mild
assessed
Mild DIARRHOEA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-21 (study day 25.0); relationship: POSSIBLE
mild
assessed
Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2013-05-21 (study day 25.0); relationship: POSSIBLE
Data queries
No data queries.